Pfizer says its COVID-19 vaccine protects younger teens
In the vaccine study of 2,260 U.S. volunteers ages 12 to 15, preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents compared to 18 among those given dummy shots, Pfizer reported. Researchers reported high levels of virus-fighting antibodies, somewhat higher than were seen in studies of young adults. AdKids had side effects similar to young adults, the company said. “We share the urgency to expand the use of our vaccine,” Pfizer CEO Albert Bourla said in a statement. One key question is the dosage: Pfizer gave the 12-and-older participants the same dose adults receive, while testing different doses in younger children.
The Latest: 6 more COVID cases found in local China outbreak
Ad___JOHNSTON, Iowa — Facing an uptick in new coronavirus cases and a hesitancy among a significant portion of the population to get the vaccine Iowa Gov. State health data shows 555 new positive cases in the past 24 hours and no additional deaths reported. Illinois Department of Public Health officials on Tuesday reported 2,404 coronavirus cases, including 17 more deaths. State health officials say 43% of people have received at least one dose of a vaccine and about 65% are fully vaccinated. ___ANKARA, Turkey — Turkey’s number of confirmed coronavirus cases reached 39,302, a record high for a second straight day.
COVID vaccine trials underway in older children: What to know
Trials with the COVID-19 vaccine for children will build on what we’ve learned from the adult trials. A vaccine for younger children isn’t expected until early next year (2022). Moderna is enrolling about 3,000 children in its COVID-19 vaccine trial. Last month, British researchers launched a trial testing the AstraZeneca in children age 12 to 17. AdRight now, a vaccine for younger children isn’t expected until early next year (2022).